I agree that this site is using cookies. You can find further informations here.
X
Hashimoto, Yasunobu
154  results:
Search for persons X
?
1

Association Between Kidney Function and Outcomes Following ..:

Ishihara, Hiroki ; Nemoto, Yuki ; Tachibana, Hidekazu...
Clinical Genitourinary Cancer.  22 (2024)  2 - p. 549-557.e5 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Survival Impact of Glucocorticoid Administration for Advers..:

Yoshino, Maki ; Ishihara, Hiroki ; Nemoto, Yuki...
Targeted Oncology.  19 (2024)  4 - p. 623-633 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Real-world outcomes of nivolumab plus ipilimumab combinatio..:

Ishihara, Hiroki ; Yuki, Nemoto ; Ishiyama, Ryo...
Japanese Journal of Clinical Oncology.  , 2024
Link: https://doi.org/10.1093/..
 
?
4

First-line dual immune checkpoint inhibitor therapies versu..:

Ishihara, Hiroki ; Omae, Kenji ; Nemoto, Yuki...
International Journal of Clinical Oncology.  29 (2024)  4 - p. 473-480 , 2024
Link: https://doi.org/10.1007/..
 
?
5

Impact of sex on prognosis in patients with advanced renal ..:

Nemoto, Yuki ; Ishihara, Hiroki ; Nakamura, Kazutaka...
Japanese Journal of Clinical Oncology.  53 (2023)  7 - p. 611-618 , 2023
Link: https://doi.org/10.1093/..
 
?
6

Comparison of Outcomes Between Therapeutic Combinations Bas..:

Ishihara, Hiroki ; Nemoto, Yuki ; Nakamura, Kazutaka...
Targeted Oncology.  18 (2023)  2 - p. 209-220 , 2023
Link: https://doi.org/10.1007/..
 
?
7

Real-world efficacy and safety of cabozantinib following im..:

Ishihara, Hiroki ; Nemoto, Yuki ; Tachibana, Hidekazu...
Japanese Journal of Clinical Oncology.  53 (2023)  10 - p. 977-983 , 2023
Link: https://doi.org/10.1093/..
 
?
8

Association between lung immune prognostic index and surviv..:

Nakamura, Kazutaka ; Ishiyama, Yudai ; Nemoto, Yuki...
International Journal of Clinical Oncology.  28 (2023)  7 - p. 913-921 , 2023
Link: https://doi.org/10.1007/..
 
?
9

Impact of Body Mass Index on Outcomes in an Asian populatio..:

Ishihara, Hiroki ; Ishiyama, Yudai ; Nemoto, Yuki...
Clinical Genitourinary Cancer.  21 (2023)  1 - p. 136-145 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Efficacy and Safety of Immunotherapy-Based Combinations as ..:

Nemoto, Yuki ; Ishihara, Hiroki ; Nakamura, Kazutaka...
Targeted Oncology.  17 (2022)  4 - p. 475-482 , 2022
Link: https://doi.org/10.1007/..
 
?
11

Therapeutic role of deferred cytoreductive nephrectomy in p..:

Yoshino, Maki ; Ishihara, Hiroki ; Nemoto, Yuki...
Japanese Journal of Clinical Oncology.  , 2022
Link: https://doi.org/10.1093/..
 
?
12

Comparison of the Impact of Immune-Related Adverse Events D..:

Ishihara, Hiroki ; Nemoto, Yuki ; Nakamura, Kazutaka...
Targeted Oncology.  18 (2022)  1 - p. 159-168 , 2022
Link: https://doi.org/10.1007/..
 
?
13

Changes in Real-World Outcomes in Patients with Metastatic ..:

Ishihara, Hiroki ; Nemoto, Yuki ; Nakamura, Kazutaka...
Targeted Oncology.  17 (2022)  3 - p. 307-319 , 2022
Link: https://doi.org/10.1007/..
 
?
14

Predictive Impact of Early Changes in Serum C-Reactive Prot..:

Tachibana, Hidekazu ; Nemoto, Yuki ; Ishihara, Hiroki...
Clinical Genitourinary Cancer.  20 (2022)  1 - p. e81-e88 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Continuation of immune checkpoint inhibitors for newly deve..:

Ishihara, Hiroki ; Fukuda, Hironori ; Yoshida, Kazuhiko...
International Journal of Urology.  30 (2022)  2 - p. 240-242 , 2022
Link: https://doi.org/10.1111/..
 
1-15